FR901228 in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine

This study is ongoing, but not recruiting participants.

Study NCT00098813 Information provided by National Cancer Institute (NCI)

First Received: December 8, 2004 Last Updated: April 14, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)

Publications:

Su YB, Tuttle RM, Fury M, et al.: A phase II study of single agent depsipeptide (DEP) in patients (pts) with radioactive iodine (RAI)-refractory, metastatic, thyroid carcinoma: preliminary toxicity and efficacy experience. [Abstract] J Clin Oncol 24 (Suppl 18): A-5554, 293s, 2006.